Mutual Fund Details

Bajaj Finserv Healthcare Fund Direct-IDCW Reinvestment

Equity Pharma

NAV

₹9.5110

as on 04 Feb 2026, 11:41 PM

₹0.0190(0.20%)

Last Change

Download the Paytm Money app now!

Invest in Stocks, F&O, Mutual Funds, IPOs, NFOS and Bonds.

Zero brokerage for 30 days
Zero account opening fees
Zero AMC for life

Scan QR code to download the app

Investment Performance

would have given a return of

₹1,03,499

₹1,06,749

₹98,356

₹1,00,032

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹32

Profit (absolute return)

0.03%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 1 month

3.66%

In the last 3 months

5.70%

In the last 6 months

3.57%

In the last 1 year

0.03%

In the last 3 years

In the last 5 years

In the last 10 years

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

Bajaj Finserv Healthcare Fund Direct-IDCW Reinvestment

as of 31 Dec 2025, 05:30 AM

₹326.75 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

1% for redemption within 3 Months

0.74%

Expense Ratio

Plan

Dividend

-1.79%

Cash Holding

Benchmark

BSE Healthcare Total Return Index

Scheme Document

View

Benchmark

BSE Healthcare Total Return Index

Exit Load

1% for redemption within 3 Months

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 31 Dec 2025

Sort By

Value

Sector

Healthcare

84.67%

₹276.66 Cr

Consumer Staples

7.78%

₹25.42 Cr

Services

3.40%

₹11.11 Cr

Materials

1.72%

₹5.62 Cr

Others

2.43%

₹7.94 Cr

Sectors Holding in this Mutual Fund

as on 31 Dec 2025

Sort By

Value

Sector

Healthcare

84.67%

₹276.66 Cr

Consumer Staples

7.78%

₹25.42 Cr

Services

3.40%

₹11.11 Cr

Materials

1.72%

₹5.62 Cr

Others

2.43%

₹7.94 Cr

Companies Holding in this Mutual Fund

as on 31 Dec 2025

Sort By

Value

Company

Divi's Laboratories Ltd.

8.85%

₹28.92 Cr

Sun Pharmaceutical Industries Ltd.

8.01%

₹26.17 Cr

Apollo Hospitals Enterprise Ltd.

5.90%

₹19.28 Cr

Aurobindo Pharma Ltd.

5.53%

₹18.07 Cr

Cipla Ltd.

5.18%

₹16.93 Cr

Others

66.53%

₹217.39 Cr

View All

Companies Holding in this Mutual Fund

as on 31 Dec 2025

Sort By

Value

Company

Divi's Laboratories Ltd.

8.85%

₹28.92 Cr

Sun Pharmaceutical Industries Ltd.

8.01%

₹26.17 Cr

Apollo Hospitals Enterprise Ltd.

5.90%

₹19.28 Cr

Aurobindo Pharma Ltd.

5.53%

₹18.07 Cr

Cipla Ltd.

5.18%

₹16.93 Cr

Others

66.53%

₹217.39 Cr

View All

Funds in this Category

This fund's returns:

0.03%

Return Duration

1 Year

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct - Growth

HDFC Pharma And Healthcare Fund Direct - Growth

WhiteOak Capital Pharma and Healthcare Fund Direct - Growth

About Bajaj Finserv Healthcare Fund Direct-IDCW Reinvestment

Bajaj Finserv Healthcare Fund Direct-IDCW Reinvestment is a Equity mutual fund scheme from Bajaj Finserv Mutual Fund. This scheme was launched on Invalid date. It has an AUM of ₹326.75 Crores and the latest NAV decalared is ₹9.511 as on 05 Feb 2026 at 5:51 pm.

Bajaj Finserv Healthcare Fund Direct-IDCW Reinvestment scheme return performance in last 1 year is 0.03%, is -5.65% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.